M. Noda

Blockade of renin-angiotensin system ameliorates renal injury in NIDDM model rats

T. Matsuo, H. Yamasaki, Y. Imura, 2000, Clinical and Experimental Nephrology.

Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure.

T. Naka, R. Fukuda, T. Matsuo, 1999, Kidney international.

Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4- yl]methyl]-1H-benzimidazole-7-carboxylic acid (CV-11974), and its prodrug, (+/-)-1-(cyclohexyloxycarbonyloxy)-ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5- yl)biphenyl

K. Kubo, Y. Inada, Masakuni Noda, 1993, The Journal of pharmacology and experimental therapeutics.

Involvement of angiotensin II in progression of renal injury in rats with genetic non-insulin-dependent diabetes mellitus (Wistar fatty rats).

T. Naka, T. Matsuo, Y. Imura, 2001, Japanese journal of pharmacology.

Inhibition of rabbit aortic angiotensin II (AII) receptor by CV-11974, a new nonpeptide AII antagonist.

K. Kubo, Y. Inada, T. Naka, 1993, Biochemical pharmacology.

Effect of an angiotensin II receptor antagonist, CV-11974, and its prodrug, TCV-116, on production of aldosterone.

Y. Inada, M. Noda, Y. Shibouta, 1994, European journal of pharmacology.

Organic anion transporting polypeptide 2‐mediated uptake of paclitaxel and 2′‐ethylcarbonate‐linked paclitaxel in freshly isolated rat hepatocytes

M. Iwaki, A. Nawa, T. Tanino, 2009, The Journal of pharmacy and pharmacology.

Effects of candesartan cilexetil (TCV-116) and enalapril in 5/6 nephrectomized rats.

Y. Imura, M. Ohta, M. Noda, 1997, Kidney international. Supplement.